These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2429941)

  • 1. In California, voluntary mass prenatal screening.
    Steinbrook R
    Hastings Cent Rep; 1986 Oct; 16(5):5-7. PubMed ID: 2429941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ancillary benefits of prenatal maternal serum screening achieved in the California program.
    Kazerouni NN; Currier RJ; Hodgkinson C; Goldman S; Lorey F; Roberson M
    Prenat Diagn; 2010 Oct; 30(10):981-7. PubMed ID: 20730796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. California's experience with low MS-AFP results.
    Lustig L; Clarke S; Cunningham G; Schonberg R; Tompkinson G
    Am J Med Genet; 1988 Sep; 31(1):211-22. PubMed ID: 2464931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum alphafetoprotein screening. University Medical Center.
    Morris N; Riconda D; Marfatia L; Ostrer H
    J Fla Med Assoc; 1991 Jun; 78(6):365-8. PubMed ID: 1714937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criticism of the California alpha fetoprotein screening program.
    Lasnover AL
    West J Med; 1987 Jan; 146(1):100. PubMed ID: 2435065
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal testing for maternal serum alpha-fetoprotein.
    Schwager EJ; Weiss BD
    Am Fam Physician; 1987 Apr; 35(4):169-74. PubMed ID: 2436465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for neural tube defects.
    Holtzman NA
    Pediatrics; 1983 Apr; 71(4):658-60. PubMed ID: 6188096
    [No Abstract]   [Full Text] [Related]  

  • 11. Mass screening for neural tube defects.
    Kolata GB
    Hastings Cent Rep; 1980 Dec; 10(6):8-10. PubMed ID: 6161904
    [No Abstract]   [Full Text] [Related]  

  • 12. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
    CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a genetic screening test ready when the lawyers say it is?
    Annas GJ
    Hastings Cent Rep; 1985 Dec; 15(6):16-8. PubMed ID: 2415480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on genetic screening: an FDA approved kit, views on early diagnosis.
    Bermel J
    Hastings Cent Rep; 1983 Oct; 13(5):3-4. PubMed ID: 11644083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
    Craig WY; Haddow JE; Palomaki GE; Roberson M
    Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. California law requires offer of AFP test.
    Scheck A
    Ob Gyn News; 1986 Feb 15-28; 21(4):3, 26. PubMed ID: 11658662
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk, autonomy, and responsibility. Informed consent for prenatal testing.
    Press N; Browner CH
    Hastings Cent Rep; 1995; 25(3):S9-12. PubMed ID: 7544327
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of women who refuse an offer of prenatal diagnosis: data from the California maternal serum alpha fetoprotein blood test experience.
    Press N; Browner CH
    Am J Med Genet; 1998 Aug; 78(5):433-45. PubMed ID: 9714010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maternal serum AFP screening in type I diabetic patients].
    Briese V
    Zentralbl Gynakol; 1989; 111(10):664-8. PubMed ID: 2473582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].
    Arbuzova SB; Nikolenko MI
    Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.